Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.
Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.
Susan Sieber, Former NCI Communications Chief, Dead.
Andrew von Eschenbach Sworn In As NCI Director.
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.
FDA Approves Abbott’s HER-2 DNA Probe Kit.
Univ. Of Pittsburgh Plans Molecular Medicine Institute.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
